Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lightpoint Medical, now a part of Telix Pharmaceuticals, is a commercial-stage medical device company specializing in miniaturized imaging and sensing tools for real-time, intraoperative cancer detection, primarily in robotic and minimally invasive surgery. Its SENSEI probe is FDA-cleared and CE-marked for use with the DaVinci robotic system, supporting the detection of cancer and sentinel lymph nodes during surgery. The company’s technology enables radiopharmaceutical-based surgical guidance, enhancing precision in cancer removal. Lightpoint’s acquisition by Telix aims to integrate molecular imaging into surgical oncology, starting with prostate and kidney cancer, with future expansion into other tumor types[7][8][10].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lightpoint Surgical.